India's Piramal Pharma up after FDA closes inspection of US plant

Piramal Pharma (Mumbai)

19/04/2023 05:23

** Shares of Piramal Pharma  PIRM.NS  rise as much as 9.6%
to 78.75 rupees, their sharpest intraday pct gain since Nov. 18
    ** The pharma company late on Tuesday said US Food and Drug
Administration (US FDA) has issued an Establishment Inspection
Report (EIR) for its manufacturing facility at Sellersville in
the US, after closing an inspection  urn:newsml:reuters.com:*:nFWN36L1FT
    ** Stock up for second straight session
    ** More than 8 mln shares traded as of 9:40 a.m. IST, 1.9
times their 30-day moving avg
    ** PIRM down over 37% YTD, as of last close

 (Reporting by Meenakshi Maidas in Bengaluru)
 ((meenakshi.maidas@thomsonreuters.com;))